Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that signals your brain to eat less and feel fuller longer—a mechanism proven in multiple randomized controlled trials. Research shows participants using semaglutide lose significantly more weight than those on diet and exercise alone. PlexusDx provides access to compounded semaglutide through licensed 503A pharmacies, serving all 50 states without insurance requirements.

How Semaglutide Works for Weight Loss

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your gut naturally produces after eating. When semaglutide binds to GLP-1 receptors in your brain's appetite center, it signals satiety—the feeling of being satisfied with less food. This mechanism also slows stomach emptying, so food stays in your digestive system longer, extending fullness between meals.

Beyond appetite suppression, semaglutide influences glucose regulation and may improve insulin sensitivity. These combined effects reduce overall calorie intake without requiring extreme dietary restriction or willpower-dependent food avoidance. The medication works 24/7, not just during meals, making consistent weight loss more achievable than traditional diet-only approaches.

Clinical Trial Results: Real Weight Loss Numbers

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program enrolled over 4,500 adults with obesity or overweight with weight-related conditions. Participants receiving 2.4 mg semaglutide weekly lost an average of 15-22% of their baseline body weight over 68 weeks, compared to 2-3% in the placebo group. This represents roughly 35-50 pounds of weight loss for a 200-pound person, sustained throughout the treatment period.

Follow-up data showed that most participants regained weight after stopping semaglutide, underscoring that the medication works best as an ongoing treatment rather than a short-term intervention. Importantly, participants who continued semaglutide after the initial trial maintained their weight loss, suggesting long-term use provides lasting benefits. These results held true across different age groups, sexes, and baseline metabolic profiles.

Semaglutide vs. Diet and Exercise Alone

While lifestyle changes—calorie reduction, increased physical activity, and behavioral modifications—form the foundation of weight management, they produce modest results for many people. Average weight loss from diet and exercise alone typically ranges 5-10% over six months, whereas semaglutide users achieve 15-22% in the same timeframe. The medication amplifies the effect of healthy habits rather than replacing them.

Combining semaglutide with structured nutrition and movement accelerates results compared to either approach independently. Some patients find that appetite suppression makes adhering to healthy eating easier because hunger signals are no longer driving food choices. PlexusDx recommends pairing your semaglutide treatment with consistent exercise and whole-food nutrition for maximum benefit and long-term metabolic health.

Who Benefits Most from Semaglutide Treatment

Semaglutide is most effective for adults with a BMI of 27 or higher (with weight-related conditions) or BMI of 30 or higher, who have struggled with conventional weight loss methods. People with insulin resistance, prediabetes, or type 2 diabetes often see additional metabolic improvements beyond weight loss. However, individual response varies based on genetics, lifestyle factors, and baseline health status.

PlexusDx's Precision Peptide Genetic Test analyzes variants in key genes—including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609—that influence how your body responds to GLP-1 therapy. These genetic insights help personalize your treatment plan and predict whether you're likely to be a strong responder or may benefit from alternative or combination approaches. Testing costs $99 as an add-on after your first month of treatment.

Safety Profile and Common Side Effects

Semaglutide is generally well-tolerated, with side effects typically mild-to-moderate and temporary. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, or constipation—usually occurring during dose escalation and improving as your body adjusts. Starting at a low dose (0.25 mg) and increasing gradually over 16 weeks minimizes these effects.

Serious side effects are rare but include pancreatitis (inflammation of the pancreas) and gallbladder issues; alert your healthcare provider immediately if you experience severe abdominal pain. Semaglutide is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. PlexusDx reviews your full medical history during the consultation process to ensure semaglutide is safe for you.

Semaglutide Injection vs. Oral Tablet Options

PlexusDx offers both compounded semaglutide injection (starting at $149/month) and oral semaglutide (starting at $249/month). The injection form is administered once weekly under the skin and delivers the full dose directly into your bloodstream, typically producing faster and more consistent results. Oral tablets are taken daily but have lower bioavailability because stomach acid and digestive enzymes break down the peptide.

Most patients achieve better weight loss outcomes with the injection due to superior absorption and dose reliability. However, some prefer oral tablets for convenience or needle hesitancy. Your PlexusDx provider will help determine which form aligns with your preferences and treatment goals. Remember: your dose may need to go up, but your price won't—whether you choose injection or oral, you pay one flat monthly rate.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see weight loss results with semaglutide?

Most patients notice reduced appetite within 1-2 weeks of starting semaglutide. Measurable weight loss (5-10 pounds) typically appears within 4-6 weeks, with steady losses continuing over the first 16 weeks as your dose increases. Peak results emerge after 3-4 months of consistent treatment.

Can semaglutide cause permanent weight loss, or will I regain weight after stopping?

Semaglutide controls weight while you're taking it; most people regain weight within months of stopping because appetite signals return to baseline. The medication works best as a long-term treatment strategy rather than a temporary fix. Continuing semaglutide maintains your weight loss, which is why PlexusDx emphasizes sustainable, ongoing therapy.

What is the actual cost of semaglutide through PlexusDx each month?

PlexusDx compounded semaglutide injection starts at $149/month flat—your dose may increase, but your price won't. Oral semaglutide starts at $249/month. No insurance is required, no membership fees apply, and HSA/FSA accounts can cover the cost if eligible under your plan.

Are there serious side effects or contraindications I should know about?

Semaglutide is contraindicated if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Rare serious side effects include pancreatitis and gallbladder inflammation. Most side effects are gastrointestinal (nausea, diarrhea) and resolve as your body adjusts; your PlexusDx provider screens for safety during consultation.

How does the Precision Peptide Genetic Test help optimize my semaglutide treatment?

PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that predict your individual response to GLP-1 therapy. Results guide dose optimization and help identify whether combination therapy (like GLP-Squared) might work better for your genetics. The test costs $99 as an add-on after your first treatment month.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves